Small Molecule oncology drugs
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
32
NCT04353791
Study of OST-122 in Patients With Moderate to Severe Ulcerative Colitis
Phase: Phase 1/2
Role: Lead Sponsor
Start: Sep 16, 2020
Completion: Dec 27, 2022
Loading map...